Mark A. Pompa, a director at Apogee Enterprises, Inc., has filed a report detailing his recent transactions involving phantom stock units and deferred restricted stock units. This filing, submitted on October 2, 2026, is significant as it reflects the ongoing commitment of directors to align their interests with those of shareholders.
The transactions were reported under a Form 4 filing, which is typically used to disclose changes in ownership of a company’s securities by its insiders. Pompa's report details that as of September 30, 2026, he acquired additional phantom stock units and deferred restricted stock units as part of his compensation as a non-employee director.
Background
Apogee Enterprises, Inc. operates in the glass products industry, specifically focusing on glass products made of purchased glass. The company is based in Minneapolis, Minnesota, and has been involved in various aspects of glass manufacturing and distribution. The recent filing is part of a series of transactions reported by Pompa, with the last similar filing occurring on July 2, 2026.
What the Filing Says
According to the filing, Pompa reported the acquisition of phantom stock units and deferred restricted stock units, stating, "The phantom stock units were allocated under the Deferred Compensation Plan for Non-Employee Directors." The filing also mentions that these units will be settled in shares of common stock following his termination from the Board or other specified events.
Impact
This update may affect Apogee Enterprises' stakeholders, including shareholders and other members of the Board of Directors. By increasing his holdings in phantom stock and restricted stock units, Pompa demonstrates confidence in the company's future performance, which may positively influence investor sentiment.
What's Next
The filing does not say what happens next.
Read Next
Saba Capital Management Disposes of Shares in PIMCO Fund
Wang Yanjun Reports Multiple Stock Sales at Sea Ltd
Summit Therapeutics' Co-CEO Exercises Stock Options for 500,000 Shares
Kim Vyacheslav Sells Shares of Kaspi.kz in Recent Transactions
Summit Therapeutics Co-CEO Exercises Stock Options for 500K Shares
King David Arnold buys 6,000 shares of Kratos Defense






